NCT06398223

Ocular Perfusion in Patients With Unilateral Carotid Artery Stenosis

Name: Clinical Trial NCT06398223
Creator: Medical University of Vienna
Keywords: Carotid Artery Stenosis, Carotid endarterectomy (CEA), procedure, clinical trial, Austria

Medical University of Vienna·ClinicalTrials.gov·procedureRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Carotid Artery Stenosis
Drug/Device/Intervention: Carotid endarterectomy (CEA)
Study type: Observational
Intervention type: procedure

Sponsor & location

Primary sponsor: Medical University of Vienna
Location: Vienna, Austria

Timeline & enrollment

Phase: N/A
Start date: Apr 09, 2024
End date: May 02, 2026
Enrollment: 45 participants

Primary outcome

Optic nerve head blood flow

Summary

The aim of the presented study is to evaluate ocular blood flow, respectively optic nerve head blood flow in patients with carotid artery stenosis before and after carotid endarterectomy or carotid artery stenting. Additionally, the investigators aim to compare optic nerve head blood flow in patients with CAS and healthy age- and sex-matched control subjects. Furthermore, the investigators intend to evaluate brain tissue oxygenation in patients with carotid artery stenosis before, during and after CEA and carotid artery stenting. Finally, the investigators will assess potential correlations between LSFG and NIRS results in patients with unilateral carotid artery stenosis.

ICD-10 classifications

Occlusion and stenosis of carotid arteryCarotid artery syndrome (hemispheric)Injury of carotid arteryAneurysm and dissection of carotid arteryOcclusion and stenosis of vertebral artery

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06398223
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06398223 through Pure Global AI's free database. This phase not specified trial is sponsored by Medical University of Vienna and is currently Recruiting. The study focuses on Carotid Artery Stenosis. Target enrollment is 45 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.